Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
12 Cards in this Set
- Front
- Back
- 3rd side (hint)
|
Bendroflumethiazide (MOA & PK)
|
MOA - Inhibit NaCl transport in the distal convoluted tubule; increases Ca2+ reabsorption
|
PK - PO; renal excretion
|
|
|
Bendroflumethiazide (CU & T)
|
CU - Hypertension; heart failure; nephroliathiasis; nephrogenic diabetes insipidus
|
T -Hypokalemic metabolic acidosis, hyperuricemia, impaired carbohydrate tolerance, hyperlipidemia, hyponatremia, allergic reactions, hemolytic anemia, thrombocytopenia; contraindicated in cirrhosis, congestive heart failure
|
|
|
Chlorothiazide (MOA & PK)
|
MOA - Inhibit NaCl transport in the distal convoluted tubule; increases Ca2+ reabsorption
|
PK - PO; renal excretion
|
|
|
Chlorothiazide (CU & T)
|
CU - Hypertension; heart failure; nephroliathiasis; nephrogenic diabetes insipidus
|
T -Hypokalemic metabolic acidosis, hyperuricemia, impaired carbohydrate tolerance, hyperlipidemia, hyponatremia, allergic reactions, hemolytic anemia, thrombocytopenia; contraindicated in cirrhosis, congestive heart failure
|
|
|
Hydrochlorothiazide (MOA & PK)
|
MOA - Inhibit NaCl transport in the distal convoluted tubule; increases Ca2+ reabsorption
|
PK - PO; renal excretion
|
|
|
Hydrochlorothiazide (CU & T)
|
CU - Hypertension; heart failure; nephroliathiasis; nephrogenic diabetes insipidus
|
T -Hypokalemic metabolic acidosis, hyperuricemia, impaired carbohydrate tolerance, hyperlipidemia, hyponatremia, allergic reactions, hemolytic anemia, thrombocytopenia; contraindicated in cirrhosis, congestive heart failure
|
|
|
Hydroflumethiazide (MOA & PK)
|
MOA - Inhibit NaCl transport in the distal convoluted tubule; increases Ca2+ reabsorption
|
PK - PO; renal excretion
|
|
|
Hydroflumethiazide (CU & T)
|
CU - Hypertension; heart failure; nephroliathiasis; nephrogenic diabetes insipidus
|
T -Hypokalemic metabolic acidosis, hyperuricemia, impaired carbohydrate tolerance, hyperlipidemia, hyponatremia, allergic reactions, hemolytic anemia, thrombocytopenia; contraindicated in cirrhosis, congestive heart failure
|
|
|
Methyclothiazide (MOA & PK)
|
MOA - Inhibit NaCl transport in the distal convoluted tubule; increases Ca2+ reabsorption
|
PK - PO; renal excretion
|
|
|
Methyclothiazide (CU & T)
|
CU - Hypertension; heart failure; nephroliathiasis; nephrogenic diabetes insipidus
|
T -Hypokalemic metabolic acidosis, hyperuricemia, impaired carbohydrate tolerance, hyperlipidemia, hyponatremia, allergic reactions, hemolytic anemia, thrombocytopenia; contraindicated in cirrhosis, congestive heart failure
|
|
|
Trichlormethiazide (MOA & PK)
|
MOA - Inhibit NaCl transport in the distal convoluted tubule; increases Ca2+ reabsorption
|
PK - PO; renal excretion
|
|
|
Trichlormethiazide (CU & T)
|
CU - Hypertension; heart failure; nephroliathiasis; nephrogenic diabetes insipidus
|
T - Hypokalemic metabolic acidosis, hyperuricemia, impaired carbohydrate tolerance, hyperlipidemia, hyponatremia, allergic reactions, hemolytic anemia, thrombocytopenia; contraindicated in cirrhosis, congestive heart failure
|
